期刊文献+

妊娠糖尿病患者血清FGF21与胰岛素抵抗及胰岛细胞功能的相关性研究 被引量:10

Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and pancreatic beta-cell functionl
下载PDF
导出
摘要 目的探讨妊娠糖尿病(GDM)患者胰岛素抵抗(IR)、胰岛细胞功能与空腹血清成纤维细胞生成因子(FGF21)之间的关系。方法选取妊娠24~28周孕妇90例,根据口服葡萄糖耐量试验(OGTT)结果均分为GDM组和正常对照(NGT)组,并根据空腹血糖(FPG)是否大于7.0mmol/L,将GDM组分为GDMl组(5.1mmol/L≤FPG〈7.0mmol/L,n=27)和GDM2组(FBG≥7.0mmol/L,n=18)两亚组。采用酶联免疫吸附(ELISA)法检测各组空腹血清FGF21水平,同时测定各受试者的体格指标及OGTT各点血糖、胰岛素和c肽等,并计算稳态模型胰岛素抵抗指数(HOMA—IR)、胰岛β细胞功能指数(HOMA—β)、胰岛素曲线下面积(AUCINS)/血糖曲线下面积(AUCGLU)和早期胰岛素分泌功能指数(△I30/△G30),分析FGF21与这些指标之间的关系。结果GDM1组和GDM2组的FGF21水平均显著高于正常对照组,差异均有统计学意义(P〈0.01);GDM2组的FGF21水平高于GDM1组,差异有统计学意义(P〈0.01)。Pearson相关分析显示,FGF21与孕前体重指数(BMI)、FPG、30minPG、1hPG、2hPG、HOMA—IR、AUCGLU呈正相关,与HOMA—β呈负相关。多元逐步线性回归分析显示,FPG是影响FGF21水平的独立影响因素。结论FGF21与IR呈正相关,与胰岛细胞功能负相关,其可能在GDM的发病机制中发挥一定作用。 Objective To investigate serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance (IR) and pancreatic beta-cell function. Methods A 75-g oral glucose tolerance test (OGTT) was performed among ninty pregnant women between 24 to 28 gestational weeks. The ninty pregnant women were averagely divided into gestational diabetes meLlitus(GDM) group and normal control(NGT) group according to OGTT. Meanwhile, based on fasting plasma glucose(FPG) weather higher than 7.0 retool/L, the GDM group was divided into GDM1 group (5. 1 mmol/L ≤ FPG 〈 7.0 retool/L, n = 27) and GDM2 group ( FBG ≥7.0 mmol/L,n = 18). Fasting serum FGF21 levels were measured by enzyme-linked immunosorbent assay(ELISA). Meanwhile, the anthropometrie parameters, glucose, insulin, e-peptide were alse measured and HOMA-insulin resistance index ( HOMA-IR), HOMA-β-cell insulin secretion index ( HOMA-β ), area under insulin ( AUCINS )/area under glucose (AUCGLU) and early insulin secretion index (△I30/△G30)were calculated. The associations of FGF21 with these parameters were analyzed. Results Serum FGF21 levels were significantly higher in patients with GDM1 and GDM2 than in controls (P 〈 0. 01 ) , and GDM2 group was also higher than GDM1 group ( P 〈 0.01 ). Fasting serum FGF21 was found to correlate positively with body mass index (BMI) before pregnancy, FPG, 30minPG, lhPG, 2hPG, HOMA-IR, and AUCGLU, but negatively with HOMA-β. Furthermore, multiple stepwise regression analysis showed that FPG was the independent influencing factor of serum FGF21 level. Conclusion FGF21 positively correlates with IR, while negatively correlates with pancreatic beta-cell functionl. FGF21 may play a role in the pathogenesis of GDM.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第12期1495-1498,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽中医学院中医药管理局重点学科-中医内分泌学科开放基金(编号:2011nfmxk004)
关键词 成纤维细胞生长因子21 妊娠糖尿病 胰岛素抵抗 胰岛细胞功能 fibroblast growth factor 21 gestational diabetes mel|itus insulin resistance pancreatic beta-cell function
  • 相关文献

参考文献13

  • 1American Diabetes Association.Diagnosis and classification of di-abetes mellitus[J].Diabetes Care,2013,36 Suppl 1:S64-74.
  • 2Lobner K,Knopff A,Baumgarten A,et al.Predictors of postpar_tum diabetes in women with gestational diabetes mellitus [J].Dia-betes,2006,55 (3 ):792-7.
  • 3Nishimura T,Nakatake Y,Konishi M,et al.Identification of anovel FGF,FGF-21,preferentially expressed in the liver [J].Biochim Biophys Acta,2000,1492(1):203-6.
  • 4Chavez AO,Molina-Carrion M,Abdul-G-hani MA,et al.Circu-lating fibroblast growth factor-21 is elevated in impaired glucosetolerance and type 2 diabetes and correlates with muscle and hepat-ic insulin resistance [J].Diabetes Care,2009,32(8 ):1542-6.
  • 5Stein S,Stepan H,Kratzsch J,et al.Serum fibroblast growth fac-tor 21 levels in gestational diabetes mellitus in relation to insulinresistance and dyslipidemia[J]? Metabolism,2010,59 ( 1 ):33-7.
  • 6Inturrisi M,Lintner N C,Sorem K A.Diagnosis and treatment ofhyperglycemia in pregnancy [J].Endocrinol Metab Clin NorthAm,2011,40(4):703-26.
  • 7Saucedo R,Zarate A,Basurto L,et al.Relationship between cir-culating adipokines and insulin resistance during pregnancy andpostpartum in women with gestational diabetes [J].Arch MedRes,2011,42(4):318-23.
  • 8Retnakaran R,Hanley A J,Raif N,et al.Adiponectin and betacell dysfunction in gestational diabetes:pathophysiological impli-cations[J].Diabetologia,2005,48 (5):993-1001.
  • 9Kharitonenkov A,Dunbar J D,Bina HA,et al.FGF-21/FGF-21receptor interaction and activation is determined by betaKlotho[J] J Cell Physiol,2008,215(1):1-7.
  • 10Kharitonenkov A,Shanafelt AB.Fibroblast growth factor-21 as atherapeutic agent for metabolic diseases [J].Bio Drugs,2008,22(1):37-44.

同被引文献52

引证文献10

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部